D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 90 Citations 29,646 339 World Ranking 413 National Ranking 202
Medicine D-index 90 Citations 30,023 359 World Ranking 7642 National Ranking 4128

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Virus
  • Disease

Her primary areas of investigation include Virology, Influenza A virus, Pediatrics, Vaccination and Virus. Alicia M. Fry has included themes like Environmental health, Oseltamivir, Polymerase chain reaction, Pandemic and Coronavirus in her Virology study. Her research investigates the connection between Influenza A virus and topics such as Human mortality from H5N1 that intersect with issues in Infant mortality.

Her studies in Pediatrics integrate themes in fields like Epidemiology, Intensive care medicine, Intention-to-treat analysis and Confidence interval. Her studies deal with areas such as Pharmacotherapy, Comorbidity and Pneumonia as well as Intensive care medicine. Her study in Influenza vaccine is interdisciplinary in nature, drawing from both Young adult, Internal medicine, H5N1 genetic structure and Influenzavirus B.

Her most cited work include:

  • Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. (1421 citations)
  • Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States (686 citations)
  • Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States (431 citations)

What are the main themes of her work throughout her whole career to date?

Alicia M. Fry mostly deals with Virology, Vaccination, Virus, Influenza vaccine and Pediatrics. Alicia M. Fry has researched Virology in several fields, including Human mortality from H5N1, Oseltamivir and Pandemic. Alicia M. Fry interconnects Transmission and Public health in the investigation of issues within Pandemic.

The Vaccination study combines topics in areas such as Seasonal influenza, Respiratory tract infections, Immunization and Confidence interval. In her research on the topic of Influenza vaccine, Immunology is strongly related with Internal medicine. Alicia M. Fry focuses mostly in the field of Pediatrics, narrowing it down to matters related to Pneumonia and, in some cases, Intensive care unit.

She most often published in these fields:

  • Virology (34.39%)
  • Vaccination (24.57%)
  • Virus (23.99%)

What were the highlights of her more recent work (between 2017-2021)?

  • Influenza vaccine (21.10%)
  • Vaccination (24.57%)
  • Virus (23.99%)

In recent papers she was focusing on the following fields of study:

Alicia M. Fry mainly investigates Influenza vaccine, Vaccination, Virus, Internal medicine and Virology. Her Influenza vaccine research is multidisciplinary, incorporating perspectives in Seasonal influenza, Respiratory illness, Confidence interval, Influenza A virus and Vaccination status. Her Influenza A virus research incorporates themes from Pandemic, Pneumonia and Infant mortality.

Her Vaccination study also includes fields such as

  • Pediatrics which intersects with area such as Comorbidity,
  • Immunization which intersects with area such as Disease. Her work on Titer as part of general Virus study is frequently linked to Interim, bridging the gap between disciplines. As part of the same scientific family, she usually focuses on Neuraminidase, concentrating on Peramivir and intersecting with Oseltamivir.

Between 2017 and 2021, her most popular works were:

  • Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. (285 citations)
  • First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. (247 citations)
  • Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa (247 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Disease

Her primary scientific interests are in Influenza vaccine, Vaccination, Pandemic, Virus and Confidence interval. Her research in Influenza vaccine intersects with topics in Seasonal influenza, Influenza A virus and Outpatient clinic. Her Influenza A virus study incorporates themes from Odds ratio, Retrospective cohort study, Pneumonia and Infant mortality.

Her Vaccination study integrates concerns from other disciplines, such as Influenza a, Clade, Immunization and Pediatrics. Her Virus research is classified as research in Virology. Her Virology research incorporates elements of Oseltamivir, Zanamivir, Neuraminidase inhibitor and Peramivir.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Seema Jain;Laurie Kamimoto;Anna M Bramley;Ann M. Schmitz.
The New England Journal of Medicine (2009)

2207 Citations

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.

Shikha Garg;Shikha Garg;Lindsay Kim;Michael Whitaker;Alissa O’Halloran.
Morbidity and Mortality Weekly Report (2020)

2201 Citations

Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States

Alicia M. Siston;Sonja A. Rasmussen;Margaret A. Honein;Alicia M. Fry.
JAMA (2010)

1088 Citations

Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

Anthony E Fiore;Alicia Fry;David Shay;Larisa Gubareva.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control (2011)

1008 Citations

Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States

Nila J. Dharan;Larisa V. Gubareva;John J. Meyer;Margaret Okomo-Adhiambo.
JAMA (2009)

729 Citations

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

Fiona P. Havers;Carrie Reed;Travis Lim;Joel M. Montgomery.
JAMA Internal Medicine (2020)

656 Citations

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.

Mark G. Thompson;Jefferey L. Burgess;Allison L. Naleway;Harmony L. Tyner.
Morbidity and Mortality Weekly Report (2021)

636 Citations

Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020.

Rachel M. Burke;Claire M. Midgley;Alissa Dratch;Martin Fenstersheib.
Morbidity and Mortality Weekly Report (2020)

591 Citations

Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.

Alicia M. Fry;David K. Shay;Robert C. Holman;Aaron T. Curns.
JAMA (2005)

578 Citations

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

Timothy M Uyeki;Henry H Bernstein;John S Bradley;John S Bradley;Janet A Englund.
Clinical Infectious Diseases (2019)

559 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alicia M. Fry

Timothy M. Uyeki

Timothy M. Uyeki

Centers for Disease Control and Prevention

Publications: 81

Benjamin J. Cowling

Benjamin J. Cowling

University of Hong Kong

Publications: 80

Arnold S. Monto

Arnold S. Monto

University of Michigan–Ann Arbor

Publications: 70

Aeron C. Hurt

Aeron C. Hurt

Roche (Switzerland)

Publications: 66

Lyn Finelli

Lyn Finelli

Centers for Disease Control and Prevention

Publications: 65

Richard K. Zimmerman

Richard K. Zimmerman

University of Pittsburgh

Publications: 63

Stephen P. Luby

Stephen P. Luby

Stanford University

Publications: 58

Cheryl Cohen

Cheryl Cohen

University of the Witwatersrand

Publications: 56

Shabir A. Madhi

Shabir A. Madhi

University of the Witwatersrand

Publications: 50

Edward A. Belongia

Edward A. Belongia

Marshfield Clinic

Publications: 49

Marc-Alain Widdowson

Marc-Alain Widdowson

Centers for Disease Control and Prevention

Publications: 48

Keith P. Klugman

Keith P. Klugman

Bill & Melinda Gates Foundation

Publications: 48

Guy Boivin

Guy Boivin

Université Laval

Publications: 47

Janet A. Englund

Janet A. Englund

Seattle Children's Hospital

Publications: 47

Jonathan A. McCullers

Jonathan A. McCullers

University of Tennessee Health Science Center

Publications: 43

Yoshihiro Kawaoka

Yoshihiro Kawaoka

University of Tokyo

Publications: 42

Trending Scientists

Mark S. Nixon

Mark S. Nixon

University of Southampton

Robert Plana

Robert Plana

Assystem (United Kingdom)

Erik Lægsgaard

Erik Lægsgaard

Aarhus University

Yueh-Lin Loo

Yueh-Lin Loo

Princeton University

Masaaki Teramoto

Masaaki Teramoto

Kyoto Institute of Technology

SonBinh T. Nguyen

SonBinh T. Nguyen

Northwestern University

M. Reza Ghadiri

M. Reza Ghadiri

Scripps Research Institute

Magnus Nordborg

Magnus Nordborg

Austrian Academy of Sciences

Mark Boothby

Mark Boothby

Vanderbilt University Medical Center

Gauthier Hulot

Gauthier Hulot

Institut de Physique du Globe de Paris

Kalevi Korpela

Kalevi Korpela

Tampere University

Charles J. Holahan

Charles J. Holahan

The University of Texas at Austin

Ronald E. LaPorte

Ronald E. LaPorte

University of Pittsburgh

Arndt Hartmann

Arndt Hartmann

University of Erlangen-Nuremberg

Pedro A. Jose

Pedro A. Jose

George Washington University

Alistair Woodward

Alistair Woodward

University of Auckland

Something went wrong. Please try again later.